Indication
Gemcitabine
3 clinical trials
3 products
2 drugs
Clinical trial
A Phase 3, Multicenter, Open-label, Randomized Study of Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone as Adjuvant Therapy in Subjects With Surgically Resected Pancreatic AdenocarcinomaStatus: Completed, Estimated PCD: 2022-06-30
Product
nab-PaclitaxelProduct
GemcitabineClinical trial
Sequential Intravesical Gemcitabine and Docetaxel for Rescue Therapy in BCG Unresponsive Non-muscle Invasive Bladder Cancer PatientsStatus: Not yet recruiting, Estimated PCD: 2026-04-09
Product
IntravesicalClinical trial
Evaluation of Concomitant Chemo-radiotherapy With Cisplatin vs Gemcitabine as the First Line of Treatment in Patients With Locally Advanced Cervical Cancer, With Comorbidities and Preserved Renal Function, is a Phase III Clinical Trial.Status: Recruiting, Estimated PCD: 2026-11-30
Drug
GemcitabineDrug
Cisplatin